birkenstock holding plc 17,927,344 Ordinary Shares Underwriting AgreementUnderwriting Agreement • May 30th, 2025 • Birkenstock Holding PLC • Footwear, (no rubber) • New York
Contract Type FiledMay 30th, 2025 Company Industry JurisdictionBK LC Lux MidCo S.à r.l., a société à responsabilité limitée, incorporated and existing under the laws of the Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies’ Register under number B252140, having its registered office at 40 avenue Monterey L-2163, Grand Duchy of Luxembourg (the “Selling Shareholder”), a shareholder of Birkenstock Holding plc, a Jersey public limited company (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 17,927,344 ordinary shares of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholder proposes to sell, at the option of the Underwriters, up to an additional 2,100,000 ordinary shares of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” Subject to the sale of the Underwritt
Underwriting AgreementUnderwriting Agreement • March 28th, 2025 • Aeluma, Inc. • Semiconductors & related devices • New York
Contract Type FiledMarch 28th, 2025 Company Industry Jurisdiction
Underwriting AgreementUnderwriting Agreement • March 25th, 2025 • Aeluma, Inc. • Semiconductors & related devices • New York
Contract Type FiledMarch 25th, 2025 Company Industry Jurisdiction
ORMAT TECHNOLOGIES, INC. 3,700,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • December 13th, 2024 • Ormat Technologies, Inc. • Electric services • New York
Contract Type FiledDecember 13th, 2024 Company Industry JurisdictionORIX Corporation, a Japanese corporation (the “Selling Stockholder”), a stockholder of Ormat Technologies, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,700,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 555,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”. To the extent that there shall be a sole Underwriter named in Schedule 1 hereto, all references to the Representatives and to the Underwriters shall be deemed to refer only to such sole Underwriter, and
UNDERWRITING AGREEMENTUnderwriting Agreement • November 27th, 2024 • Curanex Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 27th, 2024 Company Industry JurisdictionCuranex Pharmaceuticals Inc,, a corporation incorporated under the law of the State of Nevada (the “Company”), agrees, subject to the terms and conditions in this agreement (this “Agreement”), to issue and sell to Dominari Securities LLC, and with the other underwriters named on Schedule I hereto. (each an “Underwriter” and together, the “Underwriters”) an aggregate of [*] shares (the “Closing Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”). No Closing Shares will be certificated. At the option of the Underwriters, the Company agrees, subject to the terms and conditions herein, to issue and sell additional Option Shares (as defined in Section 3(b) hereof). The Closing Shares and the Option Shares are herein referred to collectively as the “Securities.” The number of Closing Shares and Option Shares to be purchased by each Underwriter is set forth opposite its name in Schedule I hereto. Each of the Underwriters has agreed to act as underwriters in connecti
Bowhead Specialty Holdings Inc. [4,000,000] Shares of Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • October 21st, 2024 • Bowhead Specialty Holdings Inc. • Fire, marine & casualty insurance • New York
Contract Type FiledOctober 21st, 2024 Company Industry JurisdictionCertain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Bowhead Specialty Holdings Inc., a Delaware corporation (the “Company”), propose, severally and not jointly, to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [4,000,000] shares of common stock, par value $0.01 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [600,000] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
Execution Version UNDERWRITING AGREEMENT SIMILARWEB LTD. 3,500,000 Ordinary Shares September 12, 2024 Goldman Sachs & Co. LLC As Representative of the several Underwriters listed in Schedule 1 hereto 200 West Street, New York, New York 10282 Ladies...Underwriting Agreement • September 16th, 2024 • Similarweb Ltd. • Services-computer programming, data processing, etc. • New York
Contract Type FiledSeptember 16th, 2024 Company Industry Jurisdiction
birkenstock holding plc [●] Ordinary Shares Underwriting AgreementUnderwriting Agreement • June 24th, 2024 • Birkenstock Holding PLC • Footwear, (no rubber) • New York
Contract Type FiledJune 24th, 2024 Company Industry JurisdictionBK LC Lux MidCo S.à r.l., a société à responsabilité limitée, incorporated and existing under the laws of the Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies’ Register under number B252140, having its registered office at 40 avenue Monterey L-2163, Grand Duchy of Luxembourg (the “Selling Shareholder”), a shareholder of Birkenstock Holding plc, a Jersey public limited company (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] ordinary shares of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholder proposes to sell, at the option of the Underwriters, up to an additional [●] ordinary shares of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The ordinary shares of the Company to be outstandi
RYMAN HOSPITALITY PROPERTIES, INC. 3,850,000 Shares of Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • June 9th, 2023 • Ryman Hospitality Properties, Inc. • Real estate investment trusts • New York
Contract Type FiledJune 9th, 2023 Company Industry JurisdictionRyman Hospitality Properties, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named on Schedule 1 hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”), 3,850,000 shares (the “Firm Shares”) of the Company’s Common Stock, $0.01 par value per share (the “Common Stock”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to an aggregate of 577,500 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the “Shares.” This is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriters.
Sovos Brands, Inc. 10,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • May 19th, 2023 • Sovos Brands, Inc. • Food and kindred products • New York
Contract Type FiledMay 19th, 2023 Company Industry JurisdictionCertain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Sovos Brands, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 12 hereof and to the extent there is only a single underwriter, the term “Underwriters” shall be deemed to refer to the single Underwriter, mutatis mutandis), an aggregate of 10,000,000 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,500,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
ORMAT TECHNOLOGIES, INC. 3,750,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • November 18th, 2022 • Ormat Technologies, Inc. • Electric services • New York
Contract Type FiledNovember 18th, 2022 Company Industry JurisdictionORIX Corporation, a Japanese corporation (the “Selling Stockholder”), a stockholder of Ormat Technologies, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,750,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 562,500 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
Altus Power, Inc. 7,000,000 Shares of Class A Common Stock Underwriting AgreementUnderwriting Agreement • September 29th, 2022 • Altus Power, Inc. • Electric services • New York
Contract Type FiledSeptember 29th, 2022 Company Industry JurisdictionThe stockholder named in Schedule 2 hereto (the “Selling Stockholder”) of Altus Power, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representatives”) an aggregate of 7,000,000 shares of Class A common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,050,000 shares of Class A common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
Underwriting AgreementUnderwriting Agreement • October 8th, 2021 • Volcon, Inc. • Motor vehicles & passenger car bodies • New York
Contract Type FiledOctober 8th, 2021 Company Industry JurisdictionAegis Capital Corp. As Representative of the several Underwriters named in Schedule I hereto c/o Aegis Capital Corp. 810 7th Avenue, 18th Floor New York, NY 10019
Common Stock Onconova Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • September 24th, 2021 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 24th, 2021 Company Industry JurisdictionGuggenheim Securities, LLC As Representative of the several Underwriters named in Schedule I attached hereto c/o Guggenheim Securities, LLC 330 Madison Avenue New York, New York 10017
Underwriting AgreementUnderwriting Agreement • September 10th, 2021 • Volcon, Inc. • Motor vehicles & passenger car bodies • New York
Contract Type FiledSeptember 10th, 2021 Company Industry JurisdictionAegis Capital Corp. As Representative of the several Underwriters named in Schedule I hereto c/o Aegis Capital Corp. 810 7th Avenue, 18th Floor New York, NY 10019
Class A Common Stock CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • July 2nd, 2021 • Chicken Soup for the Soul Entertainment, Inc. • Services-allied to motion picture production • New York
Contract Type FiledJuly 2nd, 2021 Company Industry JurisdictionGuggenheim Securities, LLC As Representative of the several Underwriters named in Schedule I attached hereto c/o Guggenheim Securities, LLC 330 Madison Avenue New York, New York 10017
MOLECULAR PARTNERS AG [●] American Depositary Shares, representing [●] Common Shares Underwriting AgreementUnderwriting Agreement • June 9th, 2021 • Molecular Partners Ag • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 9th, 2021 Company Industry JurisdictionThe Offered ADSs are to be issued pursuant to a deposit agreement (the “Deposit Agreement”), to be dated as of the Closing Date (as hereinafter defined) among the Company,
2,000,000 Ordinary Shares, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • June 7th, 2021 • Cambium Networks Corp • Radio & tv broadcasting & communications equipment • New York
Contract Type FiledJune 7th, 2021 Company Industry JurisdictionCertain shareholders of Cambium Networks Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”) named in Schedule 2 hereto (the “Selling Shareholders”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 2,000,000 Ordinary Shares, par value $0.0001 per share, of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional 300,000 Ordinary Shares of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The outstanding Ordinary Shares of the Company are referred to herein as the “Stock”.
2,205,883 Shares NLIGHT, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2021 • Nlight, Inc. • Semiconductors & related devices • New York
Contract Type FiledMarch 4th, 2021 Company Industry JurisdictionnLIGHT, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”) an aggregate of 2,205,883 shares (the “Firm Shares”) of the common stock, par value $0.0001 per share, of the Company (“Common Stock”). The Company also proposes to sell to the several Underwriters, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, up to an additional 330,882 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares.”
Duck Creek Technologies, Inc. 9,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • February 9th, 2021 • Accenture PLC • Services-business services, nec • New York
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionDuck Creek Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 90,000 shares of common stock (the “Primary Shares”), par value $0.01 per share (“Common Stock”), and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”), including Disco (Guernsey) Holdings L.P. Inc. (the “Apax Selling Stockholder”) and Accenture LLP (“Accenture”), propose to sell to the underwriters, an aggregate of 9,000,000 shares of Common Stock of the Company (the “Secondary Shares” and, together with the Primary Shares, the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,350,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stoc
SEER, INC. [●] Shares of Class A Common Stock, par value $0.00001 Underwriting AgreementUnderwriting Agreement • January 25th, 2021 • Seer, Inc. • Laboratory analytical instruments • New York
Contract Type FiledJanuary 25th, 2021 Company Industry JurisdictionSeer, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of Class A common stock, par value $0.00001 per share, of the Company, and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several underwriters an aggregate of [●] shares of Class A common stock, par value $0.00001 per share, of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters up to an additional [●] shares of Class A common stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A common stock of the Company to be outstanding after giving effect to the sale of the Shares a
EQT CORPORATION 20,000,000 Shares Common Stock (no par value) Underwriting AgreementUnderwriting Agreement • October 30th, 2020 • EQT Corp • Crude petroleum & natural gas • New York
Contract Type FiledOctober 30th, 2020 Company Industry Jurisdiction
Vertiv Holdings Co 20,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • August 6th, 2020 • Vertiv Holdings Co • Electronic components, nec • New York
Contract Type FiledAugust 6th, 2020 Company Industry Jurisdictionseveral Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282
RYMAN HOSPITALITY PROPERTIES, INC. 3,000,000 Shares of Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • December 12th, 2019 • Ryman Hospitality Properties, Inc. • Real estate investment trusts • New York
Contract Type FiledDecember 12th, 2019 Company Industry JurisdictionRyman Hospitality Properties, Inc., a Delaware corporation (the "Company"), proposes to sell to the several underwriters named on Schedule 1 hereto (the "Underwriters") for whom you are acting as representatives (the "Representatives"), 3,000,000 shares (the "Firm Shares") of the Company's Common Stock, $0.01 par value per share (the "Common Stock"). In addition, the Company proposes to grant to the Underwriters an option to purchase up to an aggregate of 450,000 additional shares of the Common Stock on the terms set forth in Section 2 (the "Option Shares"). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the "Shares." This is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriters.
Tufin Software Technologies Ltd. [ ] Ordinary Shares Underwriting AgreementUnderwriting Agreement • December 2nd, 2019 • Tufin Software Technologies Ltd. • Services-computer integrated systems design • New York
Contract Type FiledDecember 2nd, 2019 Company Industry JurisdictionCertain shareholders of Tufin Software Technologies Ltd., a company organized under the laws of the State of Israel (the “Company”) named in Schedule 2 hereto (the “Selling Shareholders”), propose, severally and not jointly, to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ] ordinary shares, par value NIS 0.015 per share (the “Ordinary Shares”) of the Company (the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [ ] Ordinary Shares (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The Ordinary Shares to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Securities”.
UNDERWRITING AGREEMENTUnderwriting Agreement • August 6th, 2019 • Silk Road Medical Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 6th, 2019 Company Industry JurisdictionCertain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Silk Road Medical, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ l ] shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [ l ] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
CISION LTD. 12,000,000 Ordinary Shares Underwriting AgreementUnderwriting Agreement • June 15th, 2018 • Cision Ltd. • Services-prepackaged software • New York
Contract Type FiledJune 15th, 2018 Company Industry JurisdictionCertain shareholders named in Schedule 2 hereto (the “Selling Shareholders”) of Cision Ltd., a Cayman Islands exempted company (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 12,000,000 ordinary shares, par value $0.0001 per share (“Ordinary Shares”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,800,000 Ordinary Shares of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The Ordinary Shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
FLAGSTAR BANCORP, INC. 8,000,000 Shares of Common Stock ($0.01 par value per share) UNDERWRITING AGREEMENTUnderwriting Agreement • June 14th, 2018 • Flagstar Bancorp Inc • Savings institution, federally chartered • New York
Contract Type FiledJune 14th, 2018 Company Industry JurisdictionMP Thrift Investments, L.P. (the “Selling Stockholder”), a stockholder of Flagstar Bancorp, Inc., a Michigan corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”; in the event that there are no other Underwriters, all plural references to Underwriters shall be deemed to be singular), for whom you are acting as representatives (the “Representatives”), an aggregate of 8,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,200,000 shares of common stock, par value $0.01 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.01 per share, of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Common Stock.”
CLEVELAND-CLIFFS INC. $275,000,000 1.50% Convertible Senior Notes due 2025 Underwriting AgreementUnderwriting Agreement • December 19th, 2017 • Cleveland-Cliffs Inc. • Metal mining • New York
Contract Type FiledDecember 19th, 2017 Company Industry JurisdictionCleveland-Cliffs Inc., an Ohio corporation (the “Company”), confirms its agreement with each of the Underwriters named in Schedule 1 hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom you are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective principal amounts set forth in said Schedule 1 of $275,000,000 aggregate principal amount of the Company’s 1.50% Convertible Senior Notes due 2025 (the “Initial Securities”) and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option to purchase all or any part of an additional $41,250,000 aggregate principal amount of its 1.50% Convertible Senior Notes due 2025 (the “Option Securities” and, together with the Initial Securities, the “Securities”). The S
Kinsale Capital Group, Inc. 3,302,736 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • May 5th, 2017 • Kinsale Capital Group, Inc. • Fire, marine & casualty insurance • New York
Contract Type FiledMay 5th, 2017 Company Industry JurisdictionCertain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Kinsale Capital Group, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,302,736 shares of common stock, par value $0.01 per share, of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional 495,409 shares of common stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
The Michaels Companies, Inc. 12,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • December 14th, 2016 • Michaels Companies, Inc. • Retail-hobby, toy & game shops • New York
Contract Type FiledDecember 14th, 2016 Company Industry JurisdictionCertain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of The Michaels Companies, Inc., a Delaware corporation (the “Company”), propose to sell to the Underwriters listed in Schedule 1 hereto (the “Underwriters”), an aggregate of 12,000,000 shares of common stock, par value $0.067751 per share (the “Common Stock”), of the Company (the “Shares”). The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”. In the event only one underwriter is listed in Schedule 1 hereto, any references in this Agreement to the “Underwriters” shall be deemed to refer to the sole underwriter in the singular form listed in such Schedule 1.
Kinsale Capital Group, Inc. 3,478,261 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • November 15th, 2016 • Kinsale Capital Group, Inc. • Fire, marine & casualty insurance • New York
Contract Type FiledNovember 15th, 2016 Company Industry JurisdictionCertain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Kinsale Capital Group, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,478,261 shares of common stock, par value $0.01 per share, of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional 521,739 shares of common stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
Underwriting AgreementUnderwriting Agreement • September 12th, 2016 • e.l.f. Beauty, Inc. • Perfumes, cosmetics & other toilet preparations • New York
Contract Type FiledSeptember 12th, 2016 Company Industry JurisdictionMorgan Stanley & Co. LLC ( “Morgan Stanley”) has agreed to reserve a portion of the Shares to be purchased by it under this Agreement for sale to the Company’s directors, officers, employees and business associates and other parties related to the Company (collectively, “Participants”), as set forth in the Prospectus (as hereinafter defined) under the heading “Underwriting” (the “Directed Share Program”). The Shares to be sold by Morgan Stanley and its affiliates pursuant to the Directed Share Program, at the direction of the Company, are referred to hereinafter as the “Directed Shares”. Any Directed Shares not orally confirmed for purchase by any Participant by the end of the business day on which this Agreement is executed will be offered to the public by the Underwriters as set forth in the Prospectus.
5,500,000 Ordinary Shares Underwriting AgreementUnderwriting Agreement • May 30th, 2014 • CaesarStone Sdot-Yam Ltd. • Cut stone & stone products • New York
Contract Type FiledMay 30th, 2014 Company Industry Jurisdiction
Everyday Health, Inc. [˜] Shares of Common Stock, Par Value $0.01 Per Share Underwriting AgreementUnderwriting Agreement • March 17th, 2014 • Everyday Health, Inc. • Services-business services, nec • New York
Contract Type FiledMarch 17th, 2014 Company Industry JurisdictionEveryday Health, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [˜] shares of common stock, par value $0.01 per share (“Common Stock”), of the Company, and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell, severally and not jointly, to the several Underwriters an aggregate of [˜] shares of Common Stock of the Company (collectively, the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [˜] shares of Common Stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred